Table 4 Assessment of zonulin levels in the migraine group according to clinical variables
From: Evaluation of zonulin levels in patients with migraine
(n = 40) | Zonulin (ng/mL) | |
|---|---|---|
r | p | |
Disease duration (years) | -0.023 | 0.887 |
Attack frequency (/month) | -0.094 | 0.562 |
Attack duration (hours) | -0.158 | 0.331 |
VAS | 0.009 | 0.955 |
Comorbidity | Mean ± SD | |
Present | 28.54 ± 8.16 (29.5) | b0.705 |
Absent | 30.24 ± 6.64 (32.2) | |
Prophylactic treatment | ||
Present | 29.62 ± 7.52 (31.4) | b0.207 |
Absent | 24.76 ± 8.15 (23.9) | |